TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transfusion Requirements After Head Trauma
Brief Summary: TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients


Options:
A: Arm Label: Shorter-storage red blood cell units; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell units stored <= 10 days | Arm Label: Longer-storage red blood cell units; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell units stored >= 21 days | Intervention Type: BIOLOGICAL; Name: Red blood cell units stored <= 10 days; Assigned to Arm(s): Shorter-storage red blood cell units | Intervention Type: BIOLOGICAL; Name: Red blood cell units stored >= 21 days; Assigned to Arm(s): Longer-storage red blood cell units
B: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Liberal transfusion strategy | Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Behavioral: Restrictive transfusion strategy | Intervention Type: BEHAVIORAL; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal | Intervention Type: BEHAVIORAL; Name: Restrictive transfusion strategy; Assigned to Arm(s): Restrictive
C: Arm Label: Liberal blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Arm Label: Restrictive blood transfusion; Type: ACTIVE_COMPARATOR; Interventions: Biological: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Liberal blood transfusion | Intervention Type: BIOLOGICAL; Name: SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion; Assigned to Arm(s): Restrictive blood transfusion
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Intervention Type: PROCEDURE; Name: red blood cell transfusion; Assigned to Arm(s): 1, 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transfusion Requirements After Head Trauma
Brief Summary: TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
B: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Intervention Type: PROCEDURE; Name: red blood cell transfusion; Assigned to Arm(s): 1, 2
D: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Liberal transfusion strategy | Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Behavioral: Restrictive transfusion strategy | Intervention Type: BEHAVIORAL; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal | Intervention Type: BEHAVIORAL; Name: Restrictive transfusion strategy; Assigned to Arm(s): Restrictive

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transfusion Requirements After Head Trauma
Brief Summary: TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients


Options:
A: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
B: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Liberal transfusion strategy | Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Behavioral: Restrictive transfusion strategy | Intervention Type: BEHAVIORAL; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal | Intervention Type: BEHAVIORAL; Name: Restrictive transfusion strategy; Assigned to Arm(s): Restrictive
C: Intervention Type: DRUG; Name: Red blood cell transfusion; Assigned to Arm(s): N/A
D: Arm Label: Low transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Arm Label: High transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: red blood cell transfusion; Assigned to Arm(s): High transfusion trigger, Low transfusion trigger

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mentorship to Promote Cardiac Rehabilitation Enrollment: A Randomized Controlled Trial
Brief Summary: The current study is a randomized controlled trial, being conducted at two hospitals in Toronto, Ontario, Canada, involving the randomization of cardiac inpatients into an intervention group, in which they will receive mentorship from a volunteer cardiac rehabilitation peer mentor, and a control group, in which they will receive usual care. Patients in both groups will be tracked to determine if they are referred to cardiac rehabilitation and if they enroll in cardiac rehabilitation. We hypothesize that compared to cardiac inpatients who receive usual care, those cardiac inpatients who receive cardiac rehabilitation peer mentorship will be more likely to be referred to and enroll in cardiac rehabilitation.


Options:
A: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship
B: Arm Label: Peer-mentoring; Type: EXPERIMENTAL; Interventions: Other: Peer-mentoring | Intervention Type: OTHER; Name: Peer-mentoring; Assigned to Arm(s): Peer-mentoring
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stepping Up to Health | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Stepping Up to Health | Intervention Type: BEHAVIORAL; Name: Stepping Up to Health; Assigned to Arm(s): 1, 2
D: Intervention Type: OTHER; Name: Peer Support; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mentorship to Promote Cardiac Rehabilitation Enrollment: A Randomized Controlled Trial
Brief Summary: The current study is a randomized controlled trial, being conducted at two hospitals in Toronto, Ontario, Canada, involving the randomization of cardiac inpatients into an intervention group, in which they will receive mentorship from a volunteer cardiac rehabilitation peer mentor, and a control group, in which they will receive usual care. Patients in both groups will be tracked to determine if they are referred to cardiac rehabilitation and if they enroll in cardiac rehabilitation. We hypothesize that compared to cardiac inpatients who receive usual care, those cardiac inpatients who receive cardiac rehabilitation peer mentorship will be more likely to be referred to and enroll in cardiac rehabilitation.


Options:
A: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship
B: Arm Label: UC; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: vCRP; Type: EXPERIMENTAL; Interventions: Behavioral: vCRP | Intervention Type: BEHAVIORAL; Name: vCRP; Assigned to Arm(s): vCRP
C: Arm Label: Extended behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Extended behavioral intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Extended behavioral intervention; Assigned to Arm(s): Extended behavioral intervention
D: Arm Label: Learning and coping arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Learning and coping arm | Arm Label: Control arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Control arm | Intervention Type: BEHAVIORAL; Name: Learning and coping arm; Assigned to Arm(s): Learning and coping arm | Intervention Type: OTHER; Name: Control arm; Assigned to Arm(s): Control arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mentorship to Promote Cardiac Rehabilitation Enrollment: A Randomized Controlled Trial
Brief Summary: The current study is a randomized controlled trial, being conducted at two hospitals in Toronto, Ontario, Canada, involving the randomization of cardiac inpatients into an intervention group, in which they will receive mentorship from a volunteer cardiac rehabilitation peer mentor, and a control group, in which they will receive usual care. Patients in both groups will be tracked to determine if they are referred to cardiac rehabilitation and if they enroll in cardiac rehabilitation. We hypothesize that compared to cardiac inpatients who receive usual care, those cardiac inpatients who receive cardiac rehabilitation peer mentorship will be more likely to be referred to and enroll in cardiac rehabilitation.


Options:
A: Arm Label: Resistance training; Type: EXPERIMENTAL; Interventions: Behavioral: Home based resistance training | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home based resistance training; Assigned to Arm(s): Resistance training
B: Arm Label: Interval training group; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise training | Arm Label: Continuous training group; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise training | Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise training; Assigned to Arm(s): Continuous training group, Interval training group
C: Arm Label: Congenital Heart Disease; Type: N/A; Interventions: N/A | Arm Label: Healthy children; Type: N/A; Interventions: N/A
D: Arm Label: Cardiac Rehabilitation Peer Mentorship; Type: EXPERIMENTAL; Interventions: Behavioral: Cardiac Rehabilitation Peer Mentorship | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cardiac Rehabilitation Peer Mentorship; Assigned to Arm(s): Cardiac Rehabilitation Peer Mentorship

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventionnal and Randomized Study Measuring Virtual Reality Cue Exposure for the Relapse Prevention of Tobacco Consumption Versus Cognitive and Behavioral Approaches Therapy
Brief Summary: The therapeutic efficacy of virtual reality has been validated for the treatment of various mental disorders ,smoking behavior is the first preventable cause of death in developed countries However, after a successful withdrawal, a high relapse rate (between 40 and 70%)has been observed, which emphasize the urgent need to implement new strategies. Virtual reality cue exposure for the relapse of tobacco consumption


Options:
A: Arm Label: Group A; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Behavioral: Quitline Service + 10 automated monitoring calls | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Behavioral: Quitline service + 20 automated monitoring calls | Intervention Type: BEHAVIORAL; Name: Quitline Service + 10 automated monitoring calls; Assigned to Arm(s): Group B | Intervention Type: BEHAVIORAL; Name: Quitline service + 20 automated monitoring calls; Assigned to Arm(s): Group C
B: Arm Label: Longitudinal Care; Type: EXPERIMENTAL; Interventions: Behavioral: smoking cessation | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: smoking cessation | Intervention Type: BEHAVIORAL; Name: smoking cessation; Assigned to Arm(s): Longitudinal Care, Usual Care
C: Arm Label: QUIT4Ever; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Drug: nicotine replacement therapy, Other: Smoking cessation counseling, Behavioral: mobile contingency management, Other: Stay Quit Coach | Arm Label: Control Contact Condition; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion, Drug: nicotine replacement therapy, Other: Smoking cessation counseling, Behavioral: mobile contingency management | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Control Contact Condition, QUIT4Ever | Intervention Type: DRUG; Name: nicotine replacement therapy; Assigned to Arm(s): Control Contact Condition, QUIT4Ever | Intervention Type: OTHER; Name: Smoking cessation counseling; Assigned to Arm(s): Control Contact Condition, QUIT4Ever | Intervention Type: BEHAVIORAL; Name: mobile contingency management; Assigned to Arm(s): Control Contact Condition, QUIT4Ever | Intervention Type: OTHER; Name: Stay Quit Coach; Assigned to Arm(s): QUIT4Ever
D: Arm Label: virtual reality exposure therapy (VRET); Type: EXPERIMENTAL; Interventions: Other: virtual reality exposure treatment | Arm Label: cognitive and behavioral approaches therapy without VRET; Type: EXPERIMENTAL; Interventions: Other: cognitive and behavioral approaches therapy | Intervention Type: OTHER; Name: virtual reality exposure treatment; Assigned to Arm(s): virtual reality exposure therapy (VRET) | Intervention Type: OTHER; Name: cognitive and behavioral approaches therapy; Assigned to Arm(s): cognitive and behavioral approaches therapy without VRET

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventionnal and Randomized Study Measuring Virtual Reality Cue Exposure for the Relapse Prevention of Tobacco Consumption Versus Cognitive and Behavioral Approaches Therapy
Brief Summary: The therapeutic efficacy of virtual reality has been validated for the treatment of various mental disorders ,smoking behavior is the first preventable cause of death in developed countries However, after a successful withdrawal, a high relapse rate (between 40 and 70%)has been observed, which emphasize the urgent need to implement new strategies. Virtual reality cue exposure for the relapse of tobacco consumption


Options:
A: Arm Label: virtual reality exposure therapy (VRET); Type: EXPERIMENTAL; Interventions: Other: virtual reality exposure treatment | Arm Label: cognitive and behavioral approaches therapy without VRET; Type: EXPERIMENTAL; Interventions: Other: cognitive and behavioral approaches therapy | Intervention Type: OTHER; Name: virtual reality exposure treatment; Assigned to Arm(s): virtual reality exposure therapy (VRET) | Intervention Type: OTHER; Name: cognitive and behavioral approaches therapy; Assigned to Arm(s): cognitive and behavioral approaches therapy without VRET
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Cognitive Behavioral Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Twelve Step Facilitation Therapy | Intervention Type: BEHAVIORAL; Name: Integrated Cognitive Behavioral Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Twelve Step Facilitation Therapy; Assigned to Arm(s): 2
C: Arm Label: Integrated care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Integrated care; Assigned to Arm(s): Integrated care | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Traditional Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Traditional Contingency Management | Arm Label: Early Enhanced Contingency Management; Type: EXPERIMENTAL; Interventions: Behavioral: Early Enhanced Contingency Management | Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Treatment | Intervention Type: BEHAVIORAL; Name: Standard Treatment; Assigned to Arm(s): Standard Treatment | Intervention Type: BEHAVIORAL; Name: Traditional Contingency Management; Assigned to Arm(s): Traditional Contingency Management | Intervention Type: BEHAVIORAL; Name: Early Enhanced Contingency Management; Assigned to Arm(s): Early Enhanced Contingency Management

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventionnal and Randomized Study Measuring Virtual Reality Cue Exposure for the Relapse Prevention of Tobacco Consumption Versus Cognitive and Behavioral Approaches Therapy
Brief Summary: The therapeutic efficacy of virtual reality has been validated for the treatment of various mental disorders ,smoking behavior is the first preventable cause of death in developed countries However, after a successful withdrawal, a high relapse rate (between 40 and 70%)has been observed, which emphasize the urgent need to implement new strategies. Virtual reality cue exposure for the relapse of tobacco consumption


Options:
A: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling (Quitline), Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) | Arm Label: Financial Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: Smoking cessation counseling (Quitline), Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy), Behavioral: Financial incentives | Intervention Type: BEHAVIORAL; Name: Smoking cessation counseling (Quitline); Assigned to Arm(s): Financial Incentives, Usual care | Intervention Type: BEHAVIORAL; Name: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy); Assigned to Arm(s): Financial Incentives, Usual care | Intervention Type: BEHAVIORAL; Name: Financial incentives; Assigned to Arm(s): Financial Incentives
B: Arm Label: virtual reality exposure therapy (VRET); Type: EXPERIMENTAL; Interventions: Other: virtual reality exposure treatment | Arm Label: cognitive and behavioral approaches therapy without VRET; Type: EXPERIMENTAL; Interventions: Other: cognitive and behavioral approaches therapy | Intervention Type: OTHER; Name: virtual reality exposure treatment; Assigned to Arm(s): virtual reality exposure therapy (VRET) | Intervention Type: OTHER; Name: cognitive and behavioral approaches therapy; Assigned to Arm(s): cognitive and behavioral approaches therapy without VRET
C: Arm Label: Longitudinal Care; Type: EXPERIMENTAL; Interventions: Behavioral: smoking cessation | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: smoking cessation | Intervention Type: BEHAVIORAL; Name: smoking cessation; Assigned to Arm(s): Longitudinal Care, Usual Care
D: Arm Label: Randomized Phase: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Randomized Phase: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Randomized Phase: Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Randomized Phase: Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Brief Summary: The investigators aim to perform the first controlled randomized prospective study using ECZ in pediatric STEC-HUS. This is of great interest as there is still no efficient specific therapy in that potentially devastating disease.

Furthermore, published data concerning the use of ECZ in STEC-HUS are controversial, reflecting statistical bias in retrospective or uncontrolled studies, thus emphasizing the need for prospective studies.


Options:
A: Arm Label: Admission/Intravascular Volume Expansion; Type: EXPERIMENTAL; Interventions: Drug: D5-0.9%NS | Arm Label: Outpatient Observation; Type: ACTIVE_COMPARATOR; Interventions: Drug: Routine home oral rehydration | Intervention Type: DRUG; Name: D5-0.9%NS; Assigned to Arm(s): Admission/Intravascular Volume Expansion | Intervention Type: DRUG; Name: Routine home oral rehydration; Assigned to Arm(s): Outpatient Observation
B: Arm Label: Stage 1 - high treatment arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: INM004 | Arm Label: Stage 1 - Low treatment arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: INM004 | Arm Label: Stage 1 - Placebo arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Stage 2 - Selected active treatment arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: INM004 | Arm Label: Stage 2 - Placebo arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: INM004; Assigned to Arm(s): Stage 1 - Low treatment arm, Stage 1 - high treatment arm, Stage 2 - Selected active treatment arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Stage 1 - Placebo arm, Stage 2 - Placebo arm
C: Arm Label: Eculizumab; Type: EXPERIMENTAL; Interventions: Drug: Eculizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Eculizumab; Assigned to Arm(s): Eculizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: SYNSORB Pk; Type: EXPERIMENTAL; Interventions: Drug: SYNSORB Pk | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SYNSORB Pk; Assigned to Arm(s): SYNSORB Pk | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C